PRELIMINARY STUDY FOR COVID-19 DRUG DISCOVERY OF 30 PHYTOCHEMICAL COMPOUNDS FROM TETRAGONULA SP. PROPOLIS AS PAK1 INHIBITOR THROUGH MOLECULAR DOCKING

Safira Candra Asih, Muhamad Sahlan, Mohammad Nasikin

Research output: Contribution to journalArticlepeer-review

Abstract

Objective: This study aims to evaluate 30 phytochemical compounds from Tetragonula sp. propolis as a PAK1 inhibitor using molecular docking. Methods: Thirty propolis compounds were initially confirmed before docking to comply with Lipinski rules. This simulation was performed against PAK1 using AutodockVina, while interaction profile visualization was conducted between the ligand and receptor through Ligplot+and PyMol. Results: Based on the docking score, inhibition constants, and interaction profile analyses, glyurallin B, glyasperin A, and broussoflavonol F were found to be the most potent compounds used as PAK1 inhibitors. According to several literature studies, the propolis compounds were synergistic, leading to adequate collective utilization. Conclusion: These results implicated the potentials of Tetragonula sp. propolis as a therapeutic agent against COVID-19; however, further studies are still needed.

Original languageEnglish
Pages (from-to)116-122
Number of pages7
JournalInternational Journal of Applied Pharmaceutics
Volume14
Issue numberSpecial Issue 3
DOIs
Publication statusPublished - 2022

Keywords

  • COVID
  • PAK1
  • Propolis
  • Tetragonula Sp.

Fingerprint

Dive into the research topics of 'PRELIMINARY STUDY FOR COVID-19 DRUG DISCOVERY OF 30 PHYTOCHEMICAL COMPOUNDS FROM TETRAGONULA SP. PROPOLIS AS PAK1 INHIBITOR THROUGH MOLECULAR DOCKING'. Together they form a unique fingerprint.

Cite this